Canada Markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
51.660.00 (0.00%)
At close: 04:00PM EDT
51.61 -0.05 (-0.10%)
After hours: 07:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 351.85
52 Week Low 314.95
50-Day Moving Average 346.19
200-Day Moving Average 330.92

Share Statistics

Avg Vol (3 month) 32.42M
Avg Vol (10 day) 31.55M
Shares Outstanding 570.03M
Implied Shares Outstanding 6N/A
Float 858.7M
% Held by Insiders 112.04%
% Held by Institutions 179.79%
Shares Short (Jul 14, 2022) 46.56M
Short Ratio (Jul 14, 2022) 45.43
Short % of Float (Jul 14, 2022) 411.42%
Short % of Shares Outstanding (Jul 14, 2022) 49.22%
Shares Short (prior month Jun 14, 2022) 45.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-507.96%

Management Effectiveness

Return on Assets (ttm)-18.47%
Return on Equity (ttm)-45.39%

Income Statement

Revenue (ttm)27.33M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)-47.30%
Gross Profit (ttm)-51.07M
EBITDA -134.79M
Net Income Avi to Common (ttm)-140.65M
Diluted EPS (ttm)-0.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)340.6M
Total Cash Per Share (mrq)4.78
Total Debt (mrq)73.86M
Total Debt/Equity (mrq)28.55
Current Ratio (mrq)5.11
Book Value Per Share (mrq)5.18

Cash Flow Statement

Operating Cash Flow (ttm)-45.22M
Levered Free Cash Flow (ttm)-55.46M